Peer Exchange

Supporting Cross-Benefit Management of Infused Drugs

Considering Cost Effectiveness in Cardiovascular Risk Reduction

Quantifying the Potential Impact of SGLT-2 Inhibitors in Heart Failure

Value-based Considerations of CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer

Managed Care Consideration for an Emerging Class of Therapy in Anemia of Chronic Kidney Disease

Patient Management of Chronic Fibrosing Interstitial Lung Disease With Progressive Phenotype